Home Heart and Cardiovascular Health Lp(a) Cholesterol: What It Is, Who Should Test, and What High Levels...

Lp(a) Cholesterol: What It Is, Who Should Test, and What High Levels Mean

14
Learn what Lp(a) cholesterol is, who should get tested, how to interpret high Lp(a) levels, and what you can do to lower your overall heart risk.

Lipoprotein(a), or Lp(a), is an inherited cholesterol-carrying particle that can raise the risk of heart attack, stroke, peripheral artery disease, and calcific aortic valve disease. Unlike LDL cholesterol, Lp(a) is controlled mainly by your genes, so healthy eating and exercise usually do not lower the number very much. That does not make the result useless. Knowing you have high Lp(a) can change how carefully you and your clinician manage the risk factors that can be changed, especially LDL cholesterol, blood pressure, smoking, diabetes, and excess weight. Many expert groups now recommend checking Lp(a) at least once in adulthood because a standard cholesterol panel does not include it. A value around 125 nmol/L or 50 mg/dL and above is generally considered high, although risk rises continuously rather than at one sharp cutoff. The result is best interpreted alongside your age, family history, other cholesterol measures, and whether you already have cardiovascular disease.

Table of Contents

What Lp(a) Is and Why It Is Different From LDL

Lp(a) is a lipoprotein particle, meaning it carries fats through the bloodstream. Structurally, it resembles an LDL particle but has an extra protein called apolipoprotein(a), or apo(a), attached to apolipoprotein B. That extra protein gives Lp(a) biological properties that make it different from ordinary LDL.

Both LDL and Lp(a) can carry cholesterol into the artery wall. Lp(a) can also carry oxidized phospholipids, molecules linked with inflammation and calcification. These features help explain why high Lp(a) is associated not only with atherosclerotic cardiovascular disease but also with narrowing of the aortic valve caused by calcium buildup.

The most important practical difference is that Lp(a) concentration is largely inherited. Variants in the LPA gene determine most of the variation from person to person. Levels can differ dramatically: one person may have almost none, while another may have several-fold higher concentrations despite similar diets, body weights, and exercise habits.

Lp(a) is also not part of a routine lipid panel. A standard panel usually reports total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. If you want to know your Lp(a), it must usually be ordered separately. If you are also trying to understand the number of atherogenic particles in your blood, ApoB testing can provide different, complementary information. ApoB counts particles that contain apolipoprotein B, while an Lp(a) test identifies the inherited risk contribution from this specific particle.

Because Lp(a) is genetically determined and usually fairly stable after childhood, most adults do not need frequent repeat testing. One well-measured result can often establish whether this risk factor is present for life.

Why High Lp(a) Matters for the Heart and Aortic Valve

High Lp(a) is considered a causal risk factor for atherosclerotic cardiovascular disease, not merely a marker that happens to travel with other risk factors. Genetic studies, population studies, and biological evidence consistently link higher lifelong exposure to greater risk.

The main conditions associated with elevated Lp(a) include:

  • Coronary artery disease and heart attack.
  • Ischemic stroke caused by blocked blood flow.
  • Peripheral artery disease affecting circulation to the limbs.
  • Calcific aortic valve stenosis, in which the heart’s aortic valve becomes stiff and narrowed.

Risk is continuous. In other words, there is no point at which Lp(a) suddenly changes from harmless to dangerous. Higher values generally indicate greater lifetime risk, while common clinical thresholds help clinicians decide when the result should meaningfully influence prevention decisions.

Lp(a) also does not act alone. A high value matters more when it is added to other risks. Someone with high Lp(a), high LDL cholesterol, high blood pressure, smoking exposure, diabetes, or established artery disease has more to gain from aggressive control of the factors that can be treated. Conversely, a high Lp(a) result does not mean a heart attack is inevitable.

This is why the result can be useful even before a dedicated Lp(a)-lowering medicine is available. It can reclassify a person who seemed to have borderline risk into a group where earlier or more intensive prevention makes sense. If your LDL cholesterol is also elevated, understanding LDL, HDL, and triglyceride levels helps put the Lp(a) result in context.

Very high Lp(a) deserves particular attention, especially with premature cardiovascular disease in the family. “Premature” usually means cardiovascular disease occurring before age 55 in a male first-degree relative or before age 65 in a female first-degree relative, although definitions vary slightly among guidelines.

Who Should Get an Lp(a) Test

Current expert guidance increasingly supports measuring Lp(a) at least once in every adult. This is a major shift from older strategies that tested only people who already looked high risk. Universal one-time testing is practical because Lp(a) is common, largely genetic, usually stable, and invisible on the standard cholesterol panel.

Testing is especially important if you have any of the following:

  • A personal history of heart attack, stroke, peripheral artery disease, or other atherosclerotic disease, particularly at a younger age.
  • A parent, sibling, or child with very high Lp(a).
  • A family history of premature cardiovascular disease that is not fully explained by standard risk factors.
  • Familial hypercholesterolemia or another condition causing very high LDL cholesterol.
  • Recurrent cardiovascular events despite apparently well-controlled LDL cholesterol and appropriate treatment.
  • Borderline or intermediate estimated cardiovascular risk when another risk-enhancing factor could change a treatment decision.
  • Calcific aortic valve disease, especially if it occurs earlier than expected.

When one person has clearly elevated Lp(a), testing first-degree relatives is often useful. This is called cascade screening. Because relatives share genes, a high result in a parent, sibling, or child makes it more likely that other family members also have elevated levels. Family testing can identify risk years before symptoms appear.

Children are not universally screened in the same way as adults in every guideline, but selective testing can be reasonable when there is familial hypercholesterolemia, a strong history of premature cardiovascular disease, or a parent with markedly elevated Lp(a). Pediatric results should be interpreted with a clinician familiar with childhood lipid disorders.

For most adults, Lp(a) testing does not require fasting. It can usually be added to blood work even if you ate beforehand, though other tests ordered at the same time may have their own instructions.

How to Read Lp(a) Results in nmol/L and mg/dL

Lp(a) can be reported in either nanomoles per liter (nmol/L) or milligrams per deciliter (mg/dL). These units measure different things. nmol/L reflects particle concentration, while mg/dL reflects mass. Because the size of the apo(a) protein varies from person to person, there is no single accurate conversion factor that works for everyone.

Do not multiply or divide your result by a fixed number to “convert” it unless the laboratory provides a validated method for its specific assay. Instead, interpret the result in the units actually reported.

A commonly used risk framework is:

Approximate categoryLp(a) in nmol/LLp(a) in mg/dL
Lower risk rangeBelow 75Below 30
Intermediate range75 to 12430 to 49
High risk range125 or higher50 or higher

These categories are useful for clinical decisions, but they should not be mistaken for biological cliffs. A result of 124 nmol/L is not suddenly safe while 125 nmol/L is dangerous. Cardiovascular risk rises across the distribution, and very high concentrations can carry substantially more risk than values just above the high-risk threshold.

The laboratory method also matters. Modern guidelines favor assays that are minimally affected by differences in apo(a) size and report particle concentration in nmol/L when possible. If a surprising result does not fit the clinical picture, discussing the assay with your clinician or laboratory may be worthwhile.

A high Lp(a) should be interpreted with the rest of your risk profile. Age, blood pressure, smoking, diabetes, kidney function, LDL cholesterol, ApoB, family history, and known cardiovascular disease all change what the number means for treatment. If the result is high but your other numbers appear “normal,” it can still be useful to review whether apparently normal cholesterol values still leave important risk unmeasured and whether additional risk assessment is appropriate.

What Can Change Lp(a) Levels—and What Usually Cannot

Genes explain most of the variation in Lp(a), so lifestyle has much less effect on this number than it has on LDL cholesterol or triglycerides. Losing weight, exercising, reducing alcohol, or following a heart-healthy diet can improve many parts of cardiovascular health without materially lowering Lp(a).

That distinction prevents two common mistakes. The first is assuming a high result means you ate the wrong foods. It usually does not. The second is assuming healthy habits are pointless because they do not lower Lp(a). They remain important because total cardiovascular risk depends on far more than one laboratory value.

Some health conditions can shift Lp(a), including significant kidney disease, severe inflammation, thyroid disease, and major changes in liver function. Hormonal states may also influence levels. These effects are usually smaller than the inherited difference between people, but they can matter when a result changes unexpectedly.

Certain medications affect Lp(a) modestly. Statins may leave Lp(a) unchanged or raise it slightly in some people, but that is not a reason to stop a statin when it is indicated. Statins lower LDL cholesterol and reduce cardiovascular events. PCSK9-inhibiting therapies can lower Lp(a) by roughly 20% to 30% on average while producing much larger reductions in LDL cholesterol, although they are prescribed primarily for LDL lowering and overall cardiovascular risk reduction rather than as dedicated Lp(a) treatment.

Diet studies are more complicated than many online claims suggest. Some dietary changes that lower LDL cholesterol can leave Lp(a) unchanged or even move it slightly upward. That does not mean the diet is worsening cardiovascular health. The more useful goal is to improve the whole risk profile. For a practical discussion of this issue, see diet and high Lp(a).

Because levels are generally stable, repeat testing is usually unnecessary after a reliable adult result. Rechecking can be reasonable if the original assay was questionable, the value was obtained during a major acute illness, or a new treatment specifically intended to lower Lp(a) becomes available and monitoring would change care.

What to Do If Your Lp(a) Is High

A high Lp(a) result is a reason to strengthen prevention, not a reason to panic. The main strategy is to reduce the cardiovascular risks that can be changed enough to offset part of the inherited risk.

Start with these priorities:

  1. **Make LDL cholesterol and ApoB a central target.** High Lp(a) often supports a lower LDL goal or earlier use of cholesterol-lowering therapy, especially if you already have cardiovascular disease or several risk factors. The exact target depends on your overall risk rather than Lp(a) alone.
  2. **Control blood pressure.** Repeated high readings add avoidable artery stress. Home measurements can help confirm whether treatment is working.
  3. **Do not smoke.** Smoking multiplies vascular risk and is especially undesirable when a strong inherited risk factor is already present.
  4. **Manage diabetes and metabolic risk.** Glucose control, physical activity, sleep, and weight management can improve several pathways that contribute to cardiovascular events.
  5. **Exercise regularly and eat for overall heart health.** These habits may not lower Lp(a), but they improve blood pressure, insulin sensitivity, fitness, body composition, and often LDL or triglycerides.
  6. **Tell close relatives.** Parents, siblings, and adult children may benefit from one-time testing because Lp(a) runs strongly in families.

Do not start aspirin solely because your Lp(a) is elevated. Aspirin can reduce clotting but can also cause serious bleeding. Its role in primary prevention is selective and depends on age, cardiovascular risk, bleeding risk, and other medical factors. People who already have cardiovascular disease may be prescribed antiplatelet therapy for reasons independent of Lp(a).

It is also useful to distinguish a high Lp(a) value from an emergency. Lp(a) itself does not cause sudden symptoms that tell you the number is high. Chest pressure, new shortness of breath, weakness on one side, facial droop, difficulty speaking, or other possible heart attack or stroke symptoms require urgent medical care regardless of your Lp(a) result.

If treatment decisions remain uncertain after standard risk assessment, your clinician may discuss additional tools such as coronary artery calcium scoring in an appropriate age group. High Lp(a) is one piece of the decision, not a stand-alone diagnosis of blocked arteries.

Lp(a) Treatments and What the Latest Research Means

As of October 2026, there is no broadly approved medication whose main indication is to lower Lp(a) and thereby prevent cardiovascular events. This is an important distinction: several drugs can change the laboratory value, but a treatment should ultimately prove that it improves outcomes people care about, such as preventing heart attacks and strokes.

Lipoprotein apheresis, a procedure that filters lipoproteins from the blood, can produce large temporary reductions in Lp(a). In the United States it is reserved for a narrow group of very high-risk patients who meet specific criteria, including severe lipid disorders and established vascular disease. It is not a routine treatment for an otherwise healthy person with an isolated high Lp(a) result.

RNA-targeted medicines have generated strong interest because they can reduce Lp(a) much more than older therapies. However, lowering the number is not automatically the same as lowering cardiovascular events. In September 2026, the phase 3 Lp(a)HORIZON trial of pelacarsen reported that the drug lowered Lp(a) but did not meet its primary endpoint for reducing major cardiovascular events compared with placebo in patients with established cardiovascular disease. Full peer-reviewed data and subgroup analyses are important for understanding that result, and other Lp(a)-targeted programs continue to be studied.

This outcome does not erase the evidence that high lifelong Lp(a) is associated with cardiovascular and aortic valve risk. It does show why clinical outcome trials are essential before assuming that a large laboratory reduction will translate into fewer events. Different drugs, amounts of lowering, treatment durations, or patient groups could produce different results, so conclusions about the entire treatment strategy should remain evidence-based rather than speculative.

For now, the actionable value of Lp(a) testing is primarily risk recognition. If your level is high, use that information to make controllable risk factors as favorable as reasonably possible and to identify relatives who may share the same inherited risk. You can also review Lp(a) treatment options and ongoing research as evidence changes.

Keep a copy of the actual laboratory report because the unit matters. Saying “my Lp(a) is 90” is incomplete: 90 mg/dL and 90 nmol/L represent very different levels. Recording the assay unit also helps when results are transferred between health systems. If family members are tested, compare each person with the laboratory’s units and clinical thresholds rather than assuming relatives will have the same value. Lp(a) is strongly inherited, but the exact concentration can still differ substantially among siblings and between parents and children.

References

Disclaimer

This article is for general educational information and is not a substitute for medical diagnosis or individualized treatment. Discuss Lp(a) results, cholesterol goals, medications, and family screening with a qualified healthcare professional who can consider your full medical history. Seek urgent medical care for symptoms that could indicate a heart attack, stroke, or another emergency.